Dexcom Inc (NASDAQ: DXCM) on Tuesday, plunged -1.00% from the previous trading day, before settling in for the closing price of $85.68. Within the past 52 weeks, DXCM’s price has moved between $57.52 and $118.80.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 22.27% over the last five years. The company achieved an average annual earnings per share of 23.52%. With a float of $386.47 million, this company’s outstanding shares have now reached $392.10 million.
The firm has a total of 10300 workers. Let’s measure their productivity. In terms of profitability, gross margin is 59.39%, operating margin of 15.25%, and the pretax margin is 17.62%.
Dexcom Inc (DXCM) Insider Activity
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Dexcom Inc is 1.44%, while institutional ownership is 93.64%. The most recent insider transaction that took place on Jun 09 ’25, was worth 546,664. Before that another transaction happened on May 27 ’25, when Company’s EVP, Chief HR Officer sold 6,184 for $85.11, making the entire transaction worth $526,318. This insider now owns 109,621 shares in total.
Dexcom Inc (DXCM) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 23.52% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 23.87% during the next five years compared to 39.06% growth over the previous five years of trading.
Dexcom Inc (NASDAQ: DXCM) Trading Performance Indicators
Dexcom Inc (DXCM) is currently performing well based on its current performance indicators. A quick ratio of 1.32 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.02. Likewise, its price to free cash flow for the trailing twelve months is 57.82.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.33, a number that is poised to hit 0.45 in the next quarter and is forecasted to reach 2.54 in one year’s time.
Technical Analysis of Dexcom Inc (DXCM)
Analysing the last 5-days average volume posted by the [Dexcom Inc, DXCM], we can find that recorded value of 2.2 million was lower than the volume posted last year of 3.98 million. As of the previous 9 days, the stock’s Stochastic %D was 42.61%. Additionally, its Average True Range was 2.29.
During the past 100 days, Dexcom Inc’s (DXCM) raw stochastic average was set at 76.41%, which indicates a significant increase from 30.25% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 22.11% in the past 14 days, which was lower than the 47.52% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $76.87, while its 200-day Moving Average is $76.47.
